Literature DB >> 23401857

Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility.

Xiaocui Zhang1, Genevieve Lavoie, Loic Fort, Edward L Huttlin, Joseph Tcherkezian, Jacob A Galan, Haihua Gu, Steven P Gygi, Sebastien Carreno, Philippe P Roux.   

Abstract

The scaffolding adapter protein Gab2 (Grb2-associated binder) participates in the signaling response evoked by various growth factors and cytokines. Gab2 is overexpressed in several human malignancies, including breast cancer, and was shown to promote mammary epithelial cell migration. The role of Gab2 in the activation of different signaling pathways is well documented, but less is known regarding the feedback mechanisms responsible for its inactivation. We now demonstrate that activation of the Ras/mitogen-activated protein kinase (MAPK) pathway promotes Gab2 phosphorylation on basic consensus motifs. More specifically, we show that RSK (p90 ribosomal S6 kinase) phosphorylates Gab2 on three conserved residues, both in vivo and in vitro. Mutation of these phosphorylation sites does not alter Gab2 binding to Grb2, but instead, we show that Gab2 phosphorylation inhibits the recruitment of the tyrosine phosphatase Shp2 in response to growth factors. Expression of an unphosphorylatable Gab2 mutant in mammary epithelial cells promotes an invasion-like phenotype and increases cell motility. Taken together, these results suggest that RSK is part of a negative-feedback loop that restricts Gab2-dependent epithelial cell motility. On the basis of the widespread role of Gab2 in receptor signaling, these findings also suggest that RSK plays a regulatory function in diverse receptor systems.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23401857      PMCID: PMC3624252          DOI: 10.1128/MCB.01353-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

Review 1.  The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.

Authors:  Benjamin G Neel; Haihua Gu; Lily Pao
Journal:  Trends Biochem Sci       Date:  2003-06       Impact factor: 13.807

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

3.  ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).

Authors:  Audrey Carriere; Yves Romeo; Hugo A Acosta-Jaquez; Julie Moreau; Eric Bonneil; Pierre Thibault; Diane C Fingar; Philippe P Roux
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

Review 4.  GAB2--a scaffolding protein in cancer.

Authors:  Sarah J Adams; Iraz T Aydin; Julide T Celebi
Journal:  Mol Cancer Res       Date:  2012-08-07       Impact factor: 5.852

5.  RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation.

Authors:  Madhurima Saha; Audrey Carriere; Mujeeburahiman Cheerathodi; Xiaocui Zhang; Geneviève Lavoie; John Rush; Philippe P Roux; Bryan A Ballif
Journal:  Biochem J       Date:  2012-10-01       Impact factor: 3.857

Review 6.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

7.  Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.

Authors:  Christine Caron; Kathleen Spring; Mélanie Laramée; Catherine Chabot; Monikca Cloutier; Haihua Gu; Isabelle Royal
Journal:  Cell Signal       Date:  2009-02-20       Impact factor: 4.315

8.  Focal amplification and oncogene dependency of GAB2 in breast cancer.

Authors:  M Bocanegra; A Bergamaschi; Y H Kim; M A Miller; A B Rajput; J Kao; A Langerød; W Han; D-Y Noh; S S Jeffrey; D G Huntsman; A-L Børresen-Dale; J R Pollack
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

9.  RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth.

Authors:  Yves Romeo; Julie Moreau; Pierre-Joachim Zindy; Marc Saba-El-Leil; Geneviève Lavoie; Farah Dandachi; Marine Baptissart; Katherine L B Borden; Sylvain Meloche; Philippe P Roux
Journal:  Oncogene       Date:  2012-07-16       Impact factor: 9.867

10.  Gab2 regulates cytoskeletal organization and migration of mammary epithelial cells by modulating RhoA activation.

Authors:  Maria Teresa Herrera Abreu; William E Hughes; Katarina Mele; Ruth J Lyons; Danny Rickwood; Brigid C Browne; Haley L Bennett; Pascal Vallotton; Tilman Brummer; Roger J Daly
Journal:  Mol Biol Cell       Date:  2010-11-30       Impact factor: 4.138

View more
  14 in total

1.  Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 To Promote a Negative-Feedback Loop That Attenuates Phosphoinositide 3-Kinase/Akt Signaling.

Authors:  Xiaocui Zhang; Geneviève Lavoie; Antoine Méant; Léo Aubert; Marie Cargnello; André Haman; Trang Hoang; Philippe P Roux
Journal:  Mol Cell Biol       Date:  2017-03-17       Impact factor: 4.272

2.  RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.

Authors:  Guoyu Yu; Yu-Chen Lee; Chien-Jui Cheng; Chuan-Fen Wu; Jian H Song; Gary E Gallick; Li-Yuan Yu-Lee; Jian Kuang; Sue-Hwa Lin
Journal:  Mol Cancer Res       Date:  2014-09-04       Impact factor: 5.852

Review 3.  ERK1/2-RSK2 Signaling in Regulation of ERα-Mediated Responses.

Authors:  Deborah A Lannigan
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

4.  Dissecting protein tyrosine phosphatase signaling by engineered chemogenetic control of its activity.

Authors:  Jordan Fauser; Vincent Huyot; Jacob Matsche; Barbara N Szynal; Yuri Alexeev; Pradeep Kota; Andrei V Karginov
Journal:  J Cell Biol       Date:  2022-07-13       Impact factor: 8.077

Review 5.  Functions of Shp2 in cancer.

Authors:  Jie Zhang; Fei Zhang; Ruifang Niu
Journal:  J Cell Mol Med       Date:  2015-06-19       Impact factor: 5.310

Review 6.  Structure and function of Gab2 and its role in cancer (Review).

Authors:  Chen-Bo Ding; Wei-Na Yu; Ji-Hong Feng; Jun-Min Luo
Journal:  Mol Med Rep       Date:  2015-06-17       Impact factor: 2.952

7.  Effects of Grb2-associated binding protein 2-specific siRNA on the migration and invasion of MG-63 osteosarcoma cells.

Authors:  Huan Wang; Hui He; Hongmei Meng; Yang Cui; Wenbo Wang
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

8.  Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.

Authors:  Jianghong Cheng; Yanhong Zhong; Shuai Chen; Yan Sun; Lantang Huang; Yujia Kang; Baozhen Chen; Gang Chen; Fengli Wang; Yingpu Tian; Wenjie Liu; Gen-Sheng Feng; Zhongxian Lu
Journal:  FASEB J       Date:  2017-08-21       Impact factor: 5.191

9.  Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells.

Authors:  Sebastian Halbach; Kristoffer Tg Rigbolt; Franziska U Wöhrle; Britta Diedrich; Christine Gretzmeier; Tilman Brummer; Jörn Dengjel
Journal:  Cell Commun Signal       Date:  2013-04-22       Impact factor: 5.712

10.  Changes in Gab2 phosphorylation and interaction partners in response to interleukin (IL)-2 stimulation in T-lymphocytes.

Authors:  Nerea Osinalde; Virginia Sánchez-Quiles; Blagoy Blagoev; Irina Kratchmarova
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.